Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Metab Brain Dis ; 26(2): 115-22, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21437673

ABSTRACT

Contrast-induced nephropathy is a common cause of acute renal failure in hospitalized patients, occurring from 24 to 48 h and up to 5 days after the administration of iodinated contrast media. Encephalopathy may accompany acute renal failure and presents with a complex of symptoms progressing from mild sensorial clouding to delirium and coma. The mechanisms responsible for neurological complications in patients with acute renal failure are still poorly known, but several studies suggest that mitochondrial dysfunction plays a crucial role in the pathogenesis of uremic encephalopathy. Thus, we measured mitochondrial respiratory chain complexes and creatine kinase activities in rat brain and kidney after administration of contrast media. Wistar rats were submitted to 6.0 ml/kg meglumine/sodium diatrizoate administration via the tail vein (acute renal failure induced by contrast media) and saline in an equal volume with the radiocontrast material (control group); 6 days after, the animals were killed and kidney and brain were obtained. The results showed that contrast media administration decreased complexes I and IV activities in cerebral cortex; in prefrontal cortex, complex I activity was inhibited. On the other hand, contrast media administration increased complexes I and II-III activities in hippocampus and striatum and complex IV activity in hippocampus. Moreover, that administration of contrast media also decreased creatine kinase activity in the cerebral cortex. The present findings suggest that the inhibition of mitochondrial respiratory chain complexes and creatine kinase caused by the acute renal failure induced by contrast media administration may be involved in the neurological complications reported in patients and might play a role in the pathogenesis of the encephalopathy caused by acute renal failure.


Subject(s)
Brain Diseases, Metabolic , Contrast Media , Creatine Kinase/metabolism , Electron Transport Chain Complex Proteins/metabolism , Energy Metabolism/physiology , Kidney Diseases , Animals , Brain/enzymology , Brain Diseases, Metabolic/etiology , Brain Diseases, Metabolic/pathology , Contrast Media/administration & dosage , Contrast Media/adverse effects , Creatinine/blood , Disease Models, Animal , Humans , Kidney/metabolism , Kidney Diseases/chemically induced , Kidney Diseases/complications , Mitochondria/metabolism , Oxidative Stress , Rats , Rats, Wistar
2.
Metab Brain Dis ; 25(2): 219-25, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20424907

ABSTRACT

We evaluated the activities of mitochondrial respiratory chain complexes in the brain of rats after renal ischemia and the effect of administration of the antioxidants N-acetylcysteine (NAC) and deferoxamine (DFX). The rats were divided into the groups: sham (control) or renal ischemia treated with saline, NAC 20 mg/kg, DFX 20 mg/kg or both antioxidants. Complex I activity was inhibited in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1 and 6 h after renal ischemia and that the treatment with a combination of NAC and DFX prevented such effect. Complex I activity was not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 12 h after renal ischemia. Complexes II and III activities were not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1, 6 and 12 h after renal ischemia. Complex IV activity was inhibited in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 1 h after renal ischemia, but the treatment with the combination of NAC and DFX was able to prevent this inhibition. Complex IV activity was not altered in hippocampus, striatum, prefrontal cortex and cerebral cortex of rats 6 and 12 h after renal ischemia. These results suggest that the inhibition of mitochondrial respiratory chain after renal ischemia might play a role in the pathogenesis of uremic encephalopathy.


Subject(s)
Acetylcysteine/pharmacology , Deferoxamine/pharmacology , Electron Transport Complex I/drug effects , Electron Transport/drug effects , Ischemia/metabolism , Ischemia/prevention & control , Kidney Diseases/metabolism , Kidney Diseases/prevention & control , Animals , Cell Respiration/drug effects , Cell Respiration/physiology , Disease Models, Animal , Drug Combinations , Drug Synergism , Electron Transport/physiology , Electron Transport Complex I/metabolism , Free Radical Scavengers/pharmacology , Ischemia/etiology , Kidney Diseases/complications , Male , Rats , Rats, Wistar
3.
Neurochem Res ; 31(11): 1375-9, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17063391

ABSTRACT

It is well described that impairment of energy production has been implicated in the pathogenesis of a number of diseases. Although several advances have occurred over the past 20 years concerning the use and administration of electroconvulsive therapy (ECT) to minimize its side effects, little progress has been made in understanding its mechanism of action. In this work, our aim was to measure the activities of mitochondrial respiratory chain complexes II and IV and succinate dehydrogenase from rat brain after acute and chronic electroconvulsive shock (ECS). Our results showed that mitochondrial respiratory chain enzymes activities were increased after acute ECS in hippocampus, striatum and cortex of rats. Besides, we also demonstrated that complex II activity was increased after chronic ECS in cortex, while hippocampus and striatum were not affected. Succinate dehydrogenase, however, was inhibited after chronic ECS in striatum, activated in cortex and not affected in hippocampus. Finally, complex IV was not affected by chronic ECS in hippocampus, striatum and cortex. Our findings demonstrated that brain metabolism is altered by ECS.


Subject(s)
Brain Chemistry/physiology , Electron Transport/physiology , Electroshock , Mitochondria/metabolism , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/enzymology , Cerebral Cortex/metabolism , Hippocampus/drug effects , Hippocampus/enzymology , Hippocampus/metabolism , Male , Neostriatum/drug effects , Neostriatum/enzymology , Neostriatum/metabolism , Rats , Rats, Wistar , Succinate Dehydrogenase/metabolism
4.
Neurochem Res ; 31(7): 877-81, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16794855

ABSTRACT

Although several advances have occurred over the past 20 years concerning the use and administration of electroconvulsive therapy to minimize side effects of this treatment, little progress has been made in understanding its mechanism of action. Creatine kinase is a crucial enzyme for brain energy homeostasis, and a decrease of its activity has been associated with neuronal death. This work was performed in order to evaluate creatine kinase activity from rat brain after acute and chronic electroconvulsive shock. Results showed an inhibition of creatine kinase activity in hippocampus, striatum and cortex, after acute and chronic electroconvulsive shock. Our findings demonstrated that creatine kinase activity is altered by electroconvulsive shock.


Subject(s)
Creatine Kinase/metabolism , Electroconvulsive Therapy , Animals , Brain/enzymology , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...